Preface ......................................................... v
Contributors ................................................... ix
Part I mRNA Synthesis, Purification, and Transfer
1 Cell Engineering with Synthetic Messenger RNA ................ 3
Peter M. Rabinovich and Sherman M. Weissman
2 In Vitro Transcription of Long RNA Containing Modified
Nucleosides ................................................. 29
Norbert Pardi, Hiromi Muramatsu, Drew Weissman, and
Katalin Karikó
3 HPLC Purification of In Vitro Transcribed Long RNA .......... 43
Drew Weissman, Norbert Pardi, Hiro Muramatsu, and Katalin
Karikó
4 Synthetic mRNAs with Superior Translation and Stability
Properties .................................................. 55
Ewa Grudzien-Nogalska, Joanna Kowalska, Wei Su, Andreas
N. Kuhn, Sergey V. Slepenkov, Edward Darzynkiewicz, Ugur
Sahin, Jacek Jemielity, and Robert E. Rhoads
5 Nonviral, Cationic Lipid-Mediated Delivery of mRNA .......... 73
James G. Hecker
6 Light-Induced mRNA Transfection ............................. 89
Sigurd Leinæs Bøe and Eivind Hovig
7 Engineering В Cells with mRNA .............................. 101
Jaewoo Lee, David Boczkowski, and Smita Nair
8 Programming Human Dendritic Cells with mRNA ................ 111
Jaewoo Lee, David Boczkowski, and Smita Nair
9 Large Volume Flow Electroporation of mRNA: Clinical Scale
Process .................................................... 127
Linhong Li, Cornell Allen, Rama Shivakumar, and
Madhusudan V. Peshwa
10 Retrovirus-Based mRNA Transfer for Transient Cell
Manipulation ............................................... 139
Melanie Galla, Axel Schambach, and Christopher Baum
11 mRNA Delivery to Human Dendritic Cells by Recombinant
Yeast and Activation of Antigen-Specific Memory T Cells .... 163
Frank Breinig, Tanja Breinig, and Manfred J. Schmitt
Part II Modulation and Monitoring of Cell Metabolism
12 Nonviral RNA Transfection to Transiently Modify T Cells
with Chimeric Antigen Receptors for Adoptive Therapy ....... 187
Tobias Riet, Astrid Holzinger, Jan Dörrie, Niels Schaft,
Gerold Schuler, and Hinrich Abken
13 Natural Killer Cell Reprogramming with Chimeric Immune
Receptors .................................................. 203
Noriko Shimasaki and Dario Саmpanа
14 Reprogramming to Pluripotency and Differentiation of
Cells with Synthetic mRNA .................................. 221
Peizhe Wang and Jie Na
15 Antitumor Vaccination with Synthetic mRNA: Strategies for
In Vitro and In Vivo Preclinical Studies ................... 235
Mustafa Diken, Sebastian Kreiter, Abderraouf Selmi, Özlem
Türeci, and Ugur Sahin
16 Mannosylated and Histidylated LPR Technology for
Vaccination with Tumor Antigen mRNA ........................ 247
Chantal Pichon and Patrick Midoux
17 Analysis of Survivin-Specific T Cells in Breast Cancer
Patients Using Human DCs Engineered with Survivin mRNA ..... 275
Özcan Met and Inge Marie Svane
18 mRNA Electroporation as a Tool for Immunomonitoring ........ 293
Nathalie Cools, Kirsten Van Camp, Viggo Van Tendeloo, and
Zwi Berneman
19 mRNA PCR-Based Epitope Chase Method ........................ 305
Jean-Daniel Doucet, Dominique Gauchat, and Réjean
Lapointe
Index ......................................................... 321
|